CX 3 CL 1 and CX 3 CR 1 expression in tertiary lymphoid structures in salivary gland infiltrates : fractalkine contribution to lymphoid neogenesis in Sjögren ’ s syndrome

Objectives. Primary SS is an autoimmune disease characterized by chronic lymphocytic inflammation and ectopic germinal centre (GC) formation within salivary glands. Fractalkine (CX3CL1), associated with the pathogenesis of RA, is the sole member of the CX3C chemokine (CK) family and acts as an adhesion and chemotactic molecule. The objectives of this work are to determine to what extent CX3CL1 and its receptor CX3CR1 expression might be altered in salivary glands obtained from patients and to establish whether these CKs might be involved in SS ectopic lymphoneogenesis. Methods. We assessed the presence of CX3CL1 protein in sera by ELISA in 21 patients with primary SS, 11 patients with Sicca syndrome (Sicca), 20 RA patients and 10 blood donors. Histological evaluation was performed on sequential sections of salivary gland tissue. Using TaqMan RT-PCR we studied CX3CL1 and CX3CR1 mRNA expression in salivary gland tissues from a molecular point of view. Results. Increased serum levels of CX3CL1 protein were observed in SS patients compared with controls (P< 0.0001) and in RA patients compared with controls (P< 0.0001), but no difference was found between Sicca patients and controls (P = 0.22). We identified histologically the cells expressing CX3CL1 and CX3CR1 in salivary glands of SS patients and we localized the molecule within tertiary lymphoid structures. Finally, the mRNA levels of the CK and its receptor were up-regulated in SS salivary glands. Conclusion. We believe that our findings point to the need for future studies on CX3CL1 and CX3CR1 proteins as contributors to the formation of ectopic GCs and possibly as a new tool in the evaluation and diagnosis of SS.

[1]  G. Proctor,et al.  Inducible Tertiary Lymphoid Structures, Autoimmunity, and Exocrine Dysfunction in a Novel Model of Salivary Gland Inflammation in C57BL/6 Mice , 2012, The Journal of Immunology.

[2]  M. Nussenzweig,et al.  Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas. , 2012, Blood.

[3]  C. Pitzalis,et al.  Ectopic lymphoid neogenesis and lymphoid chemokines in Sjogren's syndrome: at the interplay between chronic inflammation, autoimmunity and lymphomagenesis. , 2012, Current pharmaceutical biotechnology.

[4]  S. Bugatti,et al.  Role of lymphoid chemokines in the development of functional ectopic lymphoid structures in rheumatic autoimmune diseases. , 2012, Immunology letters.

[5]  Ulrich Wagner,et al.  Follicular Dendritic Cells Emerge from Ubiquitous Perivascular Precursors , 2012, Cell.

[6]  D. Cai,et al.  Fractalkine stimulates cell growth and increases its expression via NF‐κB pathway in RA‐FLS , 2012, International journal of rheumatic diseases.

[7]  A. Koch,et al.  Pathological Role of Fractalkine/CX3CL1 in Rheumatic Diseases: A Unique Chemokine with Multiple Functions , 2012, Front. Immun..

[8]  S. Gay,et al.  A BAFF/APRIL-dependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce AID expression and Ig class-switching in B cells , 2011, Annals of the rheumatic diseases.

[9]  J. Patel,et al.  Role of the CX3CL1-CX3CR1 axis in chronic inflammatory lung diseases. , 2010, International journal of clinical and experimental medicine.

[10]  P. Allavena,et al.  Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer , 2010, Journal of Neuroimmunology.

[11]  A. Manzo,et al.  Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling , 2010, Immunological reviews.

[12]  Jinfang Shen,et al.  Silencing CX3CR1 production modulates the interaction between dendritic and endothelial cells , 2010, Molecular Biology Reports.

[13]  S. Lira,et al.  CX3CR1 Is Expressed by Human B Lymphocytes and Meditates CX3CL1 Driven Chemotaxis of Tonsil Centrocytes , 2009, PloS one.

[14]  T. Kodama,et al.  The role of fractalkine as an accelerating factor on the autoimmune exocrinopathy in mice. , 2009, Investigative ophthalmology & visual science.

[15]  Stephen Kelly,et al.  Ectopic Lymphoid Structures Support Ongoing Production of Class-Switched Autoantibodies in Rheumatoid Synovium , 2009, PLoS medicine.

[16]  M. Molloy,et al.  Fractalkine in rheumatoid arthritis: a review to date. , 2008, Rheumatology.

[17]  H. Drexhage,et al.  Altered fractalkine cleavage potentially promotes local inflammation in NOD salivary gland , 2008, Arthritis research & therapy.

[18]  G. Valesini,et al.  CXCL13, CCL21, and CXCL12 Expression in Salivary Glands of Patients with Sjögren’s Syndrome and MALT Lymphoma: Association with Reactive and Malignant Areas of Lymphoid Organization1 , 2008, The Journal of Immunology.

[19]  Takahiro Shibata,et al.  Dose-Dependent Differential Regulation of Cytokine Secretion from Macrophages by Fractalkine1 , 2007, The Journal of Immunology.

[20]  C. Weyand,et al.  Fractalkine mediates T cell-dependent proliferation of synovial fibroblasts in rheumatoid arthritis. , 2007, Arthritis and rheumatism.

[21]  M. McGurk,et al.  Activation-Induced Cytidine Deaminase Expression in Follicular Dendritic Cell Networks and Interfollicular Large B Cells Supports Functionality of Ectopic Lymphoid Neogenesis in Autoimmune Sialoadenitis and MALT Lymphoma in Sjögren’s Syndrome1 , 2007, The Journal of Immunology.

[22]  A. Tzioufas,et al.  Sjögren’s Syndrome—Study of Autoantigens and Autoantibodies , 2007, Clinical reviews in allergy & immunology.

[23]  Steffen Jung,et al.  The chemokine receptor CX3CR1 mediates homing of MHC class II-positive cells to the normal mouse corneal epithelium. , 2007, Investigative ophthalmology & visual science.

[24]  H. Makino,et al.  Recruitment of CD16+ monocytes into synovial tissues is mediated by fractalkine and CX3CR1 in rheumatoid arthritis patients. , 2007, Acta medica Okayama.

[25]  S. Lira,et al.  Interaction of mature CD3+CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid. , 2006, The Journal of clinical investigation.

[26]  N. Kamatani,et al.  Soluble fractalkine in the cerebrospinal fluid of patients with neuropsychiatric lupus , 2006, Annals of the rheumatic diseases.

[27]  Masao Tanaka,et al.  Fractalkine in rheumatoid arthritis and allied conditions , 2006, Modern rheumatology.

[28]  F. Aloisi,et al.  Lymphoid neogenesis in chronic inflammatory diseases , 2006, Nature Reviews Immunology.

[29]  J. Michel,et al.  Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  G. Valesini,et al.  Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome. , 2005, Arthritis and rheumatism.

[31]  N. Miyasaka,et al.  Inhibition of Fractalkine Ameliorates Murine Collagen-Induced Arthritis1 , 2004, The Journal of Immunology.

[32]  E. S. Baekkevold,et al.  Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis. , 2004, Blood.

[33]  P. Conigliaro,et al.  Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate , 2004, Arthritis research & therapy.

[34]  S. Dewhurst,et al.  Immunohistochemical Assessment of Fractalkine, Inflammatory Cells, and Human Herpesvirus 7 in Human Salivary Glands , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[35]  T. Imaizumi,et al.  Regulation of CX3CL1/fractalkine expression in endothelial cells. , 2004, Journal of atherosclerosis and thrombosis.

[36]  C. Berek T-cell-dependent immune responses, germinal center development, and the analysis of V-gene sequences. , 2004, Methods in molecular biology.

[37]  R. Jonsson,et al.  Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. , 2003, Arthritis and rheumatism.

[38]  C. Vitali Classification criteria for Sjögren’s syndrome , 2003, Annals of the rheumatic diseases.

[39]  A. Foussat,et al.  Deregulation of the expression of the fractalkine/fractalkine receptor complex in HIV-1-infected patients. , 2001, Blood.

[40]  A. Tzioufas,et al.  "Lymphoid" chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren's syndrome patients: possible participation in lymphoid structure formation. , 2001, Arthritis and rheumatism.

[41]  J. Cyster,et al.  Follicular stromal cells and lymphocyte homing to follicles , 2000, Immunological reviews.

[42]  C. Sassetti,et al.  Mast cells migrate, but do not degranulate, in response to fractalkine, a membrane-bound chemokine expressed constitutively in diverse cells of the skin. , 2000, European journal of immunology.

[43]  J. Tschopp,et al.  Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations , 1999, The Journal of experimental medicine.

[44]  T. Schall,et al.  Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up‐regulated upon dendritic cell maturation , 1999, European journal of immunology.

[45]  T. Schall,et al.  Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion , 1997, Cell.

[46]  Wei Wang,et al.  A new class of membrane-bound chemokine with a CX3C motif , 1997, Nature.

[47]  D. Isenberg,et al.  Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. , 1993, Arthritis and rheumatism.

[48]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[49]  D. Chisholm,et al.  Labial salivary gland biopsy in Sjögren's disease , 1968, Journal of clinical pathology.